Literature DB >> 31111823

One year in review 2019: pathogenesis of rheumatoid arthritis.

Cristina Croia1, Roberto Bursi2, Donatella Sutera1, Fiorella Petrelli1, Alessia Alunno2, Ilaria Puxeddu3.   

Abstract

Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease influenced by both genetic and environmental factors. Over the last few years, particular attention has been given to novel genes and to the close interaction between genetic factors and epigenetic mechanisms. Research has also focused on the influence of environmental factors on disease development, and on new mechanisms of the innate and adaptive immune system that can influence the different stages of RA. However, there are still several aspects of the disease that need further investigation. Shedding some light on the different aspects of RA pathogenesis will help to improve the current diagnostic tools and to identify new targets for the development of disease-modifying therapies. Thus, in this review we summarise the new insights in RA pathogenesis, resulting from literature research data published in the last year.

Entities:  

Mesh:

Year:  2019        PMID: 31111823

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  44 in total

1.  The expression of GAS5, THRIL, and RMRP lncRNAs is increased in T cells of patients with rheumatoid arthritis.

Authors:  Mozhgan Moharamoghli; Vahideh Hassan-Zadeh; Elahe Dolatshahi; Zahra Alizadeh; Ali Farazmand
Journal:  Clin Rheumatol       Date:  2019-07-25       Impact factor: 2.980

2.  [Rheumatoid arthritis combined with pigmented villonodular synovitis: A case report and literature review].

Authors:  J J Peng; T Liu
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2020-12-18

3.  Angiotensin-(1-7) attenuates collagen-induced arthritis via inhibiting oxidative stress in rats.

Authors:  Juan Liu; Yan Liu; Wenyou Pan; Yongsheng Li
Journal:  Amino Acids       Date:  2021-01-04       Impact factor: 3.520

4.  Repurposing monoamine oxidase inhibitors (MAOI) for the treatment of rheumatoid arthritis possibly through modulating reactive oxidative stress mediated inflammatory cytokines.

Authors:  Debjeet Sur; Arpan Dutta; Chaitali Mondal; Apurba Banerjee; Pallab Kanti Haldar; Himangshu Sekhar Maji; Asis Bala
Journal:  Inflammopharmacology       Date:  2022-03-10       Impact factor: 4.473

Review 5.  Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases.

Authors:  Jinsha Liu; Joey Paolo Ting; Shams Al-Azzam; Yun Ding; Sepideh Afshar
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

Review 6.  The p53 status in rheumatoid arthritis with focus on fibroblast-like synoviocytes.

Authors:  Mahdi Taghadosi; Mehrnoosh Adib; Ahmadreza Jamshidi; Mahdi Mahmoudi; Elham Farhadi
Journal:  Immunol Res       Date:  2021-05-13       Impact factor: 2.829

7.  CircASH2L facilitates tumor-like biologic behaviours and inflammation of fibroblast-like synoviocytes via miR-129-5p/HIPK2 axis in rheumatoid arthritis.

Authors:  Xia Li; Meiting Qu; Jie Zhang; Kuanyin Chen; Xianghui Ma
Journal:  J Orthop Surg Res       Date:  2021-05-08       Impact factor: 2.359

8.  Synergistic effect of Bruton's tyrosine kinase and TNF-α in the regulation of rheumatoid arthritis and underlying mechanisms.

Authors:  Jinwan Du
Journal:  Exp Ther Med       Date:  2021-12-14       Impact factor: 2.447

9.  A1 and A2A adenosine receptors play a protective role to reduce prevalence of autoimmunity following tissue damage.

Authors:  Reut Riff; Oshri Naamani; Julia Mazar; Yosef S Haviv; Cidio Chaimovitz; Amos Douvdevani
Journal:  Clin Exp Immunol       Date:  2021-06-02       Impact factor: 5.732

10.  Marker Genes Change of Synovial Fibroblasts in Rheumatoid Arthritis Patients.

Authors:  Lifen Liao; Ke Liang; Lan Lan; Jinheng Wang; Jun Guo
Journal:  Biomed Res Int       Date:  2021-06-04       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.